The strengths of this study lay in the prospectively collected data, the high recruitment rate, which decreased selection bias, a large sample size , the use of a systematic protocol to follow Hb decrease until stabilization, and inclusion of both control and occult PPH groups. This evidence concerns the gene GSTM1 and pulmonary arterial hypertension.